$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 12, 2025)
$2.81B
Market Cap
-
P/E Ratio
-2.05
EPS
$48.45
52 Week High
$16.50
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Ascentage Pharma Group International (AAPG) is a pioneering clinical-stage biotechnology firm headquartered in Suzhou, China, dedicated to the development of transformative therapies for cancer, chronic hepatitis B virus (HBV), and age-related diseases. Leveraging proprietary drug discovery technologies, Ascentage seeks to address critical unmet medical needs, making significant contributions to oncology and infectious disease treatment. With a robust pipeline and a commitment to innovation, the company is strategically positioned to capitalize on growth opportunities within the dynamic biotechnology sector both in China and globally.
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
IQ
TNYA
KAVL
ORCL
SOFI
PFE
ADAP
DNN
HPE
F
AAL
PLTD
KVUE
NFLX
WBD
VHAI
WULF
MARA
UGRO
RR
PLTR
BYND
VALE
BAC
SNAP
CLSK
APLT
IVP
BITF
AMD
IREN
IRBT
T
GOOGL
RIG
RKLB
QBTS
CVE
NIO
ASBP
HOOD
RGTI
CIFR
GRAB
CAN
SMR
CMG
MTSR
SOUN
JBLU
KIND
MU
HL
IBRX
NOK
AG
BTBT
APLD
CDE
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
IQ
TNYA
KAVL
ORCL
SOFI
PFE
ADAP
DNN
HPE
F
AAL
PLTD
KVUE
NFLX
WBD
VHAI
WULF
MARA
UGRO
RR
PLTR
BYND
VALE
BAC
SNAP
CLSK
APLT
IVP
BITF
AMD
IREN
IRBT
T
GOOGL
RIG
RKLB
QBTS
CVE
NIO
ASBP
HOOD
RGTI
CIFR
GRAB
CAN
SMR
CMG
MTSR
SOUN
JBLU
KIND
MU
HL
IBRX
NOK
AG
BTBT
APLD
CDE